PALANGKA RAYA – EXECUTIVE ADMINISTRATION BUREAU. The Central Kalimantan Covid-19 Handling Task Force led by Governor H. Sugianto Sabran again delivered a Press Release regarding the progress of handling the Covid-19 pandemic in Central Kalimantan, Wednesday (12/1/2022).

In its release, as with the Central Covid-19 Handling Task Force, the Task Force Team said that the POM Agency from January 10, 2022 approved 5 types of Covid-19 vaccines as boosters, namely CoronaVac or Bio Farma Covid-19 Vaccine, Pfizer Vaccine, AstraZeneca Vaccine, Vaccine Moderna, and the Zifivax Vaccine.

These five vaccines are categorized as homologous, heterologous, or both. Homologous means that the type of primary vaccine or the initial complete dose of vaccine is the same as the type of booster vaccine, while the heterologous types of primary and booster vaccines are different. The booster vaccine is currently intended for ages 18 years and over and is given at least 6 months after having the complete primary dose of vaccine. The amount of dose received will be adjusted to the recommendations that have been given by POM.

The Central Kalimantan Covid-19 Task Force Team also appealed that apart from vaccination, the implementation of health protocols as a living habit is a demand in dealing with the Covid-19 pandemic. This is due to some people have complied with health protocols, but there are still others who lack the awareness to apply the 5M principles: wearing masks, washing hands with soap or cleaning hands with sanitizer, maintaining distance, reducing mobility, and avoiding crowds.

It is hoped that 5M’s healthy behavior can be a very important prevention effort. The Covid-19 prevention strategy by the Central Kalimantan Covid-19 Task Force for Behavior Change is focused on increasing 5M compliance. Everyone must be willing and able to make changes to 5M compliance behavior, so as to prevent the transmission of Covid-19.

Finally, the Central Kalimantan Covid-19 Handling Task Force Team conveyed the accumulated data as of today, Wednesday (12/1/2022), where there were no additional confirmed positive Covid-19 patients in Central Kalimantan, bringing the total to 46727 people. There was an addition of 1 person recovered, bringing the total to 45128 people. And, there were no additional patients died, bringing the total to 1590 people. The mortality rate (CFR) is 3.4%.

Regarding the achievement of the vaccination target of 2,036,104, the realization of Dose I Vaccination at Central Kalimantan Province level has reached 81.36%. All regencies/municipality in Central Kalimantan have achieved more than 70% of dose I vaccination.

For the achievement of vaccinations for teachers and education personnel, (High Schools) SMA, and equivalent vocational schools (SMK), the realization of PNS/GTT/PTT Vaccinations did not increase so that it remained at 6,258 or 79.01%. The first dose of SMA/SMK was not added, so it remained at 73.202 or 76.95%, and the second dose of SMA/SMK was not added, so it remained at 32,403 or 34.06%. (may/trans.by feb)